United Therapeutics (UTHR) EBT Margin (2009 - 2026)
United Therapeutics (UTHR) posted EBT Margin of 40.73% for Q1 2026, down 27.51% sequentially from 56.19% in Q4 2025, and down 1258.0% YoY from 3.52% in Q1 2025.
United Therapeutics (UTHR) EBT Margin (2009 - 2026) Analysis & Trends
United Therapeutics has reported EBT Margin for 18 years, with the latest figure at 40.73% in Q1 2026.
- Quarterly EBT Margin fell 1258.0% year-over-year to 40.73% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 50.75% (down 148.0% YoY) and the FY2025 annual result came in at 53.85%, up 36.0% from the prior year.
- EBT Margin slipped to 40.73% in Q1 2026 per UTHR's latest filing, from 56.19% in the prior quarter.
- Over five years, EBT Margin peaked at 66.83% in Q1 2022 and troughed at 32.26% in Q2 2022.
- A 5-year average of 52.12% and a median of 53.88% in 2024 frame the typical range for EBT Margin.
- The widest YoY moves for EBT Margin: up 5826 bps in 2022, down 1623 bps in 2022.
- Over 5 years, EBT Margin stood at 36.38% in 2022, then jumped by 32 bps to 48.06% in 2023, then climbed by 12 bps to 53.88% in 2024, then gained by 4 bps to 56.19% in 2025, then fell by 28 bps to 40.73% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 40.73%, 56.19%, and 54.78% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | -0.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.58% |
| Mar 31, 2026 | 40.73% |
| Dec 31, 2025 | 56.19% |
| Sep 30, 2025 | 54.78% |
| Jun 30, 2025 | 51.14% |
| Mar 31, 2025 | 53.31% |
| Dec 31, 2024 | 53.88% |
| Sep 30, 2024 | 51.89% |
| Jun 30, 2024 | 49.70% |
| Mar 31, 2024 | 58.82% |
| Dec 31, 2023 | 48.06% |
| Sep 30, 2023 | 57.73% |
| Jun 30, 2023 | 56.19% |
| Mar 31, 2023 | 57.59% |
| Dec 31, 2022 | 36.38% |
| Sep 30, 2022 | 60.56% |
| Jun 30, 2022 | 32.26% |
| Mar 31, 2022 | 66.83% |
| Dec 31, 2021 | 33.84% |
| Sep 30, 2021 | 45.96% |